可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Naghshtabrizi B,Shakerian F,Hajilooi M,et al.Plasma homocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiography[J].J Cardiovasc Dis Res,2012,3(4):276-279.
[2]Isilak Z,Kardesoglu E,Aparci M,et al.Comparison of clinical risk assessment systems in predicting three-vessel coronary artery disease and angiographic culprit lesion in patients with non-ST segment elevated myocardial infarction/unstable angina pectoris[J].Kardiol Pol,2012,70(3): 242-250.
[3]Wang ZL,Qian SM,Zhang HM.Effect of Xin’anning Nasal Drop in treating coronary heart disease with unstable angina pectoris[J]. Chin J Integr Med, 2006,12(4):301-305.
[4]叶 辉,严江涛,邵娇梅,等.血浆同型半胱氨酸水平及亚甲基四氢叶酸还原酶基因突变与脑卒中关系的病例对照研究[J].中华流行病学杂志,2004,25(11):958-961.
[5]叶 辉,邵娇梅,蒋键刚,等.血同型半胱氨酸与心脑血管疾病关系随访研究[J].心脏杂志,2006,18(1):60-61,64.
[6]Cacciapuoti F.Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors[J].Blood Coagul Fibrinolysis,2012,23(8):677-679.